01 / 12
Enquirer Consulting Group / Prepared for Medicovestor
September 2026

The IND is in.
The partner list is the next build.

You gave Keira's sign-off a thumbs up, so rather than let the thread go quiet we built the page anyway. It asks nothing of you today. It is a short read on how the partner search could run alongside the clinical work.
DesignBuildRunHand over
BUILDRUNOWN
Enquirer AI is the outbound engine of Enquirer Consulting Group
What we see

The science has milestones. The partner search has a calendar.

01
You announced the IND submission for MC001 in the first days of September, on the back of Orphan Drug Designation for the same pancreatic program.
02
Two platforms and more than two programs now, across pancreatic, ovarian and an indication outside oncology. Each reaches a different set of partners.
03
The Sanyou agreement shows a deal can be done here. It also shows the shape of how they arrive, through relationships and partnering weeks rather than a system that runs every week.
04
The route forward is licensing, co-development and investment. So the plan rests on reaching a specific set of named companies, and the named people inside them.
Your own releases end with an open door: parties interested in strategic collaboration or investment are welcome to reach out. That works for the ones who find you, not the ones who never do.
Prepared for Medicovestor
Where this goes

From a door held open to a list that gets worked.

Today
.
Partner conversations start at conferences, in pitch rooms and in your own network.
.
Between partnering weeks the outreach slows, because it runs on relationships and calendars rather than on a system.
.
The news is real and it is published. Most of the companies who should see it do not.
.
Nobody goes back to the business development lead who said not right now last spring.
In the first weeks and months
+
A named list of business development, licensing and search and evaluation teams in pharma and biotech, agreed with you before anything goes out.
+
Every one of them contacted personally, on a rhythm that does not depend on the conference calendar.
+
Positive replies land with you and your operator, with the person and a way to reach them.
+
At four months you own the list, the messaging, the tooling and the person running it.
Enquirer Consulting Group
How the engagement works

Build. Run. Own.

01 / BUILD

Build

We design, staff and stand up the complete unit. The named-account data, the messaging, the outbound engine, the automation and the reporting.

02 / RUN

Run

We run it in market for a fixed four months and prove it on real booked meetings, not slides. First conversations land early.

03 / OWN

Own

We hand over the playbook, the tooling, the dashboards and a trained operator. You own the engine.

One contractor, a network of specialists. One point of contact, and you never manage a stack of tools or freelancers.
We build it, run it in market, then hand you the keys
What we build for Medicovestor

Three things, matched to a licensing motion.

The named partner list

Business development, licensing and search and evaluation teams working in solid tumors and antibody drug conjugates, plus the investors who follow the space. Named companies and named people, agreed with you before a single message goes out.

Outreach that survives a scientific reader

Every message researched and written for one person, on email and on LinkedIn together. Technical enough for a chief scientific officer, short enough for a business development lead. No templates.

The operator and the handover

We design it, staff it and run it in market for four months, then hand over the playbook, the tooling, the dashboards and a trained operator. You keep all of it.

We are not going to hand you a menu of twelve disciplines. The gap we can see from the outside is reach into a small and nameable set of companies, so that is the thing we would build.
Enquirer Consulting Group
The engine, in plain terms

Every message, written for one real person.

01

Target

We build the named list with you: the pharma and biotech teams who license and partner on ADC assets, and the exact people inside them.

02

Personalize

AI reads each profile and writes a unique message. No templates.

03

Hand off warm

A positive reply pings you and your operator with the prospect and a way to reach them.

04

You take it from there

You take pre-qualified conversations. The engine handles everything before it.

Research-led and human-reviewed. Every message is on-brand, and most of the volume runs on capacity we operate, not only your account.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Why this shape fits Medicovestor

Few names on the list. Every one of them worth the work.

01

The list is countable

A licensing motion does not need a million contacts. It needs the right few hundred companies worked properly and worked again, which is exactly what a built unit does better than a founder with a full week.

02

You do not need outbound explained

You were a clinical research director in oncology at a global pharmaceutical company, and you led hematology and oncology divisions at three US medical schools. The gap is not knowing what good looks like. It is having a unit that runs without you in the middle of it.

03

You own it at the end

Four months, then it is yours. With the IND in and more than one program behind it, that puts the partner engine in place before the conversations that matter most.

Enquirer Consulting Group
Proof, in the field

Numbers from live campaigns, not projections.

Tim Rath
Chief Operating Officer, Innovative Radiology
Enquirer AI helps us identify the right people and start the conversation in a much smarter way.
$10M+
New business sold for clients.
3,500+
Qualified conversations generated.
100,000+
Decision makers reached for clients.
Fixed engagement, then you own it.
Why ECG

You own it at the end. That is the difference.

+
Without building an outbound team from scratch.
+
Without a permanent agency on retainer forever.
+
Without a stack of tools and freelancers to manage.
+
Without lock-in. You own the engine, including the operator who runs it.
A freelancer sends emails. An agency rents you reps. A consultancy hands you a slide deck. We design the engine, staff it, run it, prove it on real meetings, then hand you the keys.
Enquirer Consulting Group
How we start

Stand up fast. Prove it. Then scale.

Stand up

Build

The named-account data, the messaging, the engine and the dashboard. Day-one capacity from warmed assets and managed seats.

Prove

The test

Run against the KPIs we agree up front. First meetings on the calendar early.

Scale

Ramp

Once the numbers hold, ramp the seats and breadth to the volume you want.

Own

Hand over

Playbook, tooling, dashboards and a trained operator. The engine is yours.

Onboarding sets the targeting and the voice first, so the outreach lands warmer every week.
Enquirer Consulting Group
Next step

No clock on this, and nothing owed.

  1. Nothing is owed here. You gave Keira's note a thumbs up, so we built the page rather than let the thread go quiet.
  2. Paul Smaldone picks this up from our side. He spends his time on the US medical and pharma side of our book, so he is the right person for a conversation about partner reach.
  3. If it ever becomes useful, twenty minutes with Paul. He would bring a first cut of the partner list, so you have something concrete to react to rather than a conversation about outbound in the abstract.
Nothing to reply to today. If it becomes useful, Paul is the person to talk to.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Enquirer Consulting Group

We build it, run it in market, then hand you the keys.

Paul Smaldone   /   paul@enquirerconsulting.com   /   cal.com/ecg
Enquirer AI is the outbound engine of Enquirer Consulting Group. Prepared for Medicovestor.